Urapidil
Sponsors
The George Institute, University Hospital, Strasbourg, France, Hu Anmin, University of Zurich, Chinese PLA General Hospital
Conditions
AgingAnesthesiaBlood Loss, SurgicalBlood PressureCVA (Cerebrovascular Accident)Cerebral HemorrhageCerebrovascular DisordersGeneral Surgery
Phase 3
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
TerminatedNCT02558023
Start: 2015-09-30End: 2020-08-31Updated: 2020-08-25
Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
CompletedNCT03790800
Start: 2020-03-20End: 2023-11-30Updated: 2025-03-26
Phase 4
Unknown Phase
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
CompletedNCT00226096
Start: 2005-11-30End: 2007-09-30Updated: 2008-06-26
Effect of High vs. Low MAP Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery
NCT02857153
Start: 2016-07-31End: 2017-10-31Target: 322Updated: 2016-08-16
Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries
CompletedNCT03497351
Start: 2018-04-15End: 2019-02-15Updated: 2020-08-26
Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage
Not yet recruitingNCT06635707
Start: 2024-11-01End: 2026-12-01Target: 600Updated: 2024-10-10
Related Papers
5 more papers not shown